Similar Posts
Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
Time To Take Tax Breaks Away From Non-Profit Hospitals
Many wealthy nonprofit hospitals provide surprisingly little charitable care.
Pandemics and Overdoses: COVID-19 May Worsen Our Opioid Epidemic
The novel coronavirus has decimated our economy at the same time as it has directly threatened our health. As if that weren’t bad enough, the economic damage Covid-19 is causing could have an indirect impact on our health. Consider what we already know about economic downturns and opioid overdoses. A research team led by Atheendar…
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic
The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the…
Medicare Pays More Money To Doctors Taking Care Of Rich Patients. Here’s Why.
It has always been financially rewarding for doctors to take care of rich patients. People with more money…well, they have more money to spend on healthcare. But shouldn’t this more money/higher payment relationship go away in Medicare? It doesn’t, and some recent payment reforms may be making matters worse. (To read the rest of the…
Preventing Diabetes – What Medicare Administrators Could Learn From Shark Tank
The Medicare Diabetes Prevention Program is a lifesaver. Consisting of of at least 16 class sessions that provide practical training about healthy eating, physical activity, and other strategies for weight control, the Program reduces the chance that people at high risk for diabetes actually develop that life-threatening condition.
However, the Program is floundering, with distressingly few people having access to or enrolling in the program. Could it be because Medicare administrators haven’t watched enough episodes of Shark Tank?
